A citation-based method for searching scientific literature

Eleonora Molinaro, Kalliopi Andrikou, Andrea Casadei-Gardini, Giulia Rovesti. Cancers (Basel) 2020
Times Cited: 3







List of co-cited articles
1 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Randomized, Double-Blind Phase II Trial With Prospective Classification by ATM Protein Level to Evaluate the Efficacy and Tolerability of Olaparib Plus Paclitaxel in Patients With Recurrent or Metastatic Gastric Cancer.
Yung-Jue Bang, Seock-Ah Im, Keun-Wook Lee, Jae Yong Cho, Eun-Kee Song, Kyung Hee Lee, Yeul Hong Kim, Joon Oh Park, Hoo Geun Chun, Dae Young Zang,[...]. J Clin Oncol 2015
190
66

Small-molecule inhibitors of lysine methyltransferases SMYD2 and SMYD3: current trends.
Edoardo Fabini, Elisabetta Manoni, Claudia Ferroni, Alberto Del Rio, Manuela Bartolini. Future Med Chem 2019
16
33

SMYD3 overexpression was a risk factor in the biological behavior and prognosis of gastric carcinoma.
Yong Liu, Xuegang Luo, Jingyu Deng, Yuan Pan, Li Zhang, Han Liang. Tumour Biol 2015
24
33

SMYD3 Promotes Homologous Recombination via Regulation of H3K4-mediated Gene Expression.
Yun-Ju Chen, Cheng-Hui Tsai, Pin-Yu Wang, Shu-Chun Teng. Sci Rep 2017
16
33


Cyclin-dependent kinase inhibitors and the treatment of gastrointestinal cancers.
Sameh Mikhail, Christopher Albanese, Michael J Pishvaian. Am J Pathol 2015
23
33

Effects of SMYD3 over-expression on cell cycle acceleration and cell proliferation in MDA-MB-231 human breast cancer cells.
Tian-nian Ren, Jing-song Wang, Yun-mian He, Chang-liang Xu, Shu-zhen Wang, Tao Xi. Med Oncol 2011
35
33

Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
Y Ito, N Matsuura, M Sakon, E Miyoshi, K Noda, T Takeda, K Umeshita, H Nagano, S Nakamori, K Dono,[...]. Hepatology 1999
146
33

In Silico/In Vitro Hit-to-Lead Methodology Yields SMYD3 Inhibitor That Eliminates Unrestrained Proliferation of Breast Carcinoma Cells.
Ilham M Alshiraihi, Dillon K Jarrell, Zeyad Arhouma, Kelly N Hassell, Jaelyn Montgomery, Alyssa Padilla, Hend M Ibrahim, Debbie C Crans, Takamitsu A Kato, Mark A Brown. Int J Mol Sci 2020
3
33

Smyd3 regulates cancer cell phenotypes and catalyzes histone H4 lysine 5 methylation.
Glenn S Van Aller, Nicolas Reynoird, Olena Barbash, Michael Huddleston, Shichong Liu, Anne-Flore Zmoos, Patrick McDevitt, Robert Sinnamon, BaoChau Le, Gloria Mas,[...]. Epigenetics 2012
120
33

Prognostic impact of ATM mutations in patients with metastatic colorectal cancer.
Giovanni Randon, Giovanni Fucà, Daniele Rossini, Alessandra Raimondi, Filippo Pagani, Federica Perrone, Elena Tamborini, Adele Busico, Giorgia Peverelli, Federica Morano,[...]. Sci Rep 2019
19
33


Network analyses elucidate the role of SMYD3 in esophageal squamous cell carcinoma.
Xinning Liu, Zhoude Zheng, Chuhong Chen, Simin Guo, Zhennan Liao, Yue Li, Ying Zhu, Haiying Zou, Jianyi Wu, Wenming Xie,[...]. FEBS Open Bio 2017
3
33

Elevated Levels of SET and MYND Domain-Containing Protein 3 Are Correlated with Overexpression of Transforming Growth Factor-β1 in Gastric Cancer.
Honggen Liu, Yong Liu, Fanming Kong, Wen Xin, Xiaojiang Li, Han Liang, Yingjie Jia. J Am Coll Surg 2015
14
33

DNA damage response and repair in colorectal cancer: Defects, regulation and therapeutic implications.
Mohammad Mirza-Aghazadeh-Attari, Saber Ghazizadeh Darband, Mojtaba Kaviani, Ainaz Mihanfar, Javad Aghazadeh Attari, Bahman Yousefi, Maryam Majidinia. DNA Repair (Amst) 2018
37
33

A proteomics analysis of cell signaling alterations in colorectal cancer.
Juan Madoz-Gúrpide, Marta Cañamero, Lydia Sanchez, José Solano, Patricia Alfonso, J Ignacio Casal. Mol Cell Proteomics 2007
71
33



Cooperation between SMYD3 and PC4 drives a distinct transcriptional program in cancer cells.
Jin-Man Kim, Kyunghwan Kim, Thomas Schmidt, Vasu Punj, Haley Tucker, Judd C Rice, Tobias S Ulmer, Woojin An. Nucleic Acids Res 2015
45
33

Synthetic lethality and cancer.
Nigel J O'Neil, Melanie L Bailey, Philip Hieter. Nat Rev Genet 2017
225
33

Overexpression of SMYD3 and matrix metalloproteinase-9 are associated with poor prognosis of patients with gastric cancer.
Yong Liu, Honggen Liu, Xuegang Luo, Jingyu Deng, Yuan Pan, Han Liang. Tumour Biol 2015
31
33

SMYD3 promotes the epithelial-mesenchymal transition in breast cancer.
Claudio Fenizia, Cinzia Bottino, Silvia Corbetta, Raffaella Fittipaldi, Pamela Floris, Germano Gaudenzi, Silvia Carra, Franco Cotelli, Giovanni Vitale, Giuseppina Caretti. Nucleic Acids Res 2019
31
33

SMYD3 promotes cancer invasion by epigenetic upregulation of the metalloproteinase MMP-9.
Alicia M Cock-Rada, Souhila Medjkane, Natacha Janski, Nadhir Yousfi, Martine Perichon, Marie Chaussepied, Johanna Chluba, Gordon Langsley, Jonathan B Weitzman. Cancer Res 2012
124
33

Knockdown of SMYD3 by RNA interference down-regulates c-Met expression and inhibits cells migration and invasion induced by HGF.
Jia-Ning Zou, Shu-Zhen Wang, Jia-Sen Yang, Xue-Gang Luo, Jing-Hang Xie, Tao Xi. Cancer Lett 2009
48
33

Exploiting DNA repair defects in colorectal cancer.
Nicole M Reilly, Luca Novara, Federica Di Nicolantonio, Alberto Bardelli. Mol Oncol 2019
39
33

SET and MYND domain-containing protein 3 decreases sensitivity to dexamethasone and stimulates cell adhesion and migration in NIH3T3 cells.
Xue-Gang Luo, Yan Ding, Qing-Feng Zhou, Liang Ye, Shu-Zhen Wang, Tao Xi. J Biosci Bioeng 2007
19
33

Editorial: Cancer Models.
Michael Breitenbach, Jens Hoffmann. Front Oncol 2018
3
33

Targeting DNA repair in cancer: current state and novel approaches.
Apostolos Klinakis, Dimitris Karagiannis, Theodoros Rampias. Cell Mol Life Sci 2020
24
33

Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas.
Yang Liu, Nilay S Sethi, Toshinori Hinoue, Barbara G Schneider, Andrew D Cherniack, Francisco Sanchez-Vega, Jose A Seoane, Farshad Farshidfar, Reanne Bowlby, Mirazul Islam,[...]. Cancer Cell 2018
177
33

Discovery of an Allosteric Ligand Binding Site in SMYD3 Lysine Methyltransferase.
Vladimir O Talibov, Edoardo Fabini, Edward A FitzGerald, Daniele Tedesco, Daniela Cederfeldt, Martin J Talu, Moira M Rachman, Filip Mihalic, Elisabetta Manoni, Marina Naldi,[...]. Chembiochem 2021
2
50

Histone methyltransferase SMYD3 promotes MRTF-A-mediated transactivation of MYL9 and migration of MCF-7 breast cancer cells.
Xue-Gang Luo, Chun-Ling Zhang, Wen-Wen Zhao, Zhi-Peng Liu, Lei Liu, Ai Mu, Shu Guo, Nan Wang, Hao Zhou, Tong-Cun Zhang. Cancer Lett 2014
40
33

Structural insights into the autoinhibition and posttranslational activation of histone methyltransferase SmyD3.
Nualpun Sirinupong, Joseph Brunzelle, Ernada Doko, Zhe Yang. J Mol Biol 2011
47
33

DNA repair and recombination factor Rad51 is over-expressed in human pancreatic adenocarcinoma.
H Maacke, K Jost, S Opitz, S Miska, Y Yuan, L Hasselbach, J Lüttges, H Kalthoff, H W Stürzbecher. Oncogene 2000
155
33

Amplification of SMYD3 promotes tumorigenicity and intrahepatic metastasis of hepatocellular carcinoma via upregulation of CDK2 and MMP2.
Yu Wang, Bin-Hui Xie, Wei-Hao Lin, Yong-Hui Huang, Jia-Yan Ni, Jie Hu, Wei Cui, Jun Zhou, Long Shen, Lin-Feng Xu,[...]. Oncogene 2019
28
33

SMYD3-associated pathway is involved in the anti-tumor effects of sulforaphane on gastric carcinoma cells.
Qing-Qing Dong, Qiu-Tong Wang, Lei Wang, Ya-Xin Jiang, Mei-Ling Liu, Hai-Jie Hu, Yong Liu, Hao Zhou, Hong-Peng He, Tong-Cun Zhang,[...]. Food Sci Biotechnol 2018
10
33

Requirement of histone methyltransferase SMYD3 for estrogen receptor-mediated transcription.
Hyunjung Kim, Kyu Heo, Jeong Hoon Kim, Kyunghwan Kim, Jongkyu Choi, Woojin An. J Biol Chem 2009
67
33

Effects of SMYD3 overexpression on transformation, serum dependence, and apoptosis sensitivity in NIH3T3 cells.
Xue-Gang Luo, Tao Xi, Shu Guo, Zhi-Peng Liu, Nan Wang, Yong Jiang, Tong-Cun Zhang. IUBMB Life 2009
24
33

Enhanced SMYD3 expression is essential for the growth of breast cancer cells.
Ryuji Hamamoto, Fabio Pittella Silva, Masataka Tsuge, Toshihiko Nishidate, Toyomasa Katagiri, Yusuke Nakamura, Yoichi Furukawa. Cancer Sci 2006
200
33

ANKHD1 is required for SMYD3 to promote tumor metastasis in hepatocellular carcinoma.
Zhenyu Zhou, Hai Jiang, Kangsheng Tu, Wei Yu, Jianlong Zhang, Zhigang Hu, Heyun Zhang, Dake Hao, Pinbo Huang, Jie Wang,[...]. J Exp Clin Cancer Res 2019
15
33

A SMYD3 Small-Molecule Inhibitor Impairing Cancer Cell Growth.
Alessia Peserico, Aldo Germani, Paola Sanese, Armenio Jorge Barbosa, Valeria Di Virgilio, Raffaella Fittipaldi, Edoardo Fabini, Carlo Bertucci, Greta Varchi, Mary Pat Moyer,[...]. J Cell Physiol 2015
58
33

C-terminal domain of SMYD3 serves as a unique HSP90-regulated motif in oncogenesis.
Mark A Brown, Kenneth Foreman, June Harriss, Chhaya Das, Li Zhu, Melissa Edwards, Salam Shaaban, Haley Tucker. Oncotarget 2015
33
33

SMYD3 promotes epithelial ovarian cancer metastasis by downregulating p53 protein stability and promoting p53 ubiquitination.
Liwei Zhang, Yue Jin, Hao Yang, Yu Li, Chao Wang, Yongheng Shi, Yu Wang. Carcinogenesis 2019
9
33

SMYD3-mediated lysine methylation in the PH domain is critical for activation of AKT1.
Yuichiro Yoshioka, Takehiro Suzuki, Yo Matsuo, Makoto Nakakido, Giichiro Tsurita, Cristiano Simone, Toshiaki Watanabe, Naoshi Dohmae, Yusuke Nakamura, Ryuji Hamamoto. Oncotarget 2016
27
33

PARP inhibitors: Synthetic lethality in the clinic.
Christopher J Lord, Alan Ashworth. Science 2017
929
33


Targeting SMYD3 to Sensitize Homologous Recombination-Proficient Tumors to PARP-Mediated Synthetic Lethality.
Paola Sanese, Candida Fasano, Giacomo Buscemi, Cinzia Bottino, Silvia Corbetta, Edoardo Fabini, Valentina Silvestri, Virginia Valentini, Vittoria Disciglio, Giovanna Forte,[...]. iScience 2020
4
33

The ATM-mediated DNA-damage response: taking shape.
Yosef Shiloh. Trends Biochem Sci 2006
411
33

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
33

FDA Approval Summary: Olaparib Monotherapy in Patients with Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer Treated with Three or More Lines of Chemotherapy.
Geoffrey Kim, Gwynn Ison, Amy E McKee, Hui Zhang, Shenghui Tang, Thomas Gwise, Rajeshwari Sridhara, Eunice Lee, Abraham Tzou, Reena Philip,[...]. Clin Cancer Res 2015
300
33

The different roles of hRAD50 in microsatellite stable and unstable colorectal cancers.
Jingfang Gao, Hong Zhang, Gunnar Arbman, Xiao-Feng Sun. Dis Markers 2008
7
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.